Differences in the Prevalence of SARS-CoV-2 Infection and Access to Care between Italians and Non-Italians in a Social-Housing Neighbourhood of Milan, Italy
- PMID: 34682369
- PMCID: PMC8535198
- DOI: 10.3390/ijerph182010621
Differences in the Prevalence of SARS-CoV-2 Infection and Access to Care between Italians and Non-Italians in a Social-Housing Neighbourhood of Milan, Italy
Abstract
The northern Italian region of Lombardy has been severely affected by the COVID-19 pandemic since its arrival in Europe. However, there are only a few published studies of the possible influence of social and cultural factors on its prevalence in the general population. This cross-sectional study of the San Siro social-housing neighbourhood of Milan, which was carried about between 23 December 2020 and 19 February 2021, found that the prevalence of anti-SARS-CoV-2 nucleocapsid antibodies in the population as a whole was 12.4% (253/2044 inhabitants), but there was a more than two-fold difference between non-Italians and Italians (23.3% vs. 9.1%). Multivariable analyses showed that being more than 50 years old, living in crowded accommodation, being a non-Italian, and having a low educational level were associated with higher odds of a positive SARS-CoV-2 test, whereas a higher level of education, retirement, and being a former or current cigarette smoker were inversely associated with SARS-CoV-2 infection. Our findings are in line with previous observations indicating that a lower socio-economic status may be a risk factor for COVID-19 and show that non-Italians are disproportionately affected by SARS-CoV-2 infection. This suggests that public health policies should focus more on disadvantaged populations.
Keywords: COVID-19; SARS-CoV-2; migrants; prevalence; social housing.
Conflict of interest statement
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
References
-
- ISTAT Primi Risultati Dell’indagine di Sieroprevalenza Sul SARS-CoV-2. [(accessed on 25 May 2021)]. Available online: https://www.istat.it/it/files/2020/08/ReportPrimiRisultatiIndagineSiero.pdf.
-
- Pagani G., Giacomelli A., Conti F., Bernacchia D., Rondanin R., Prina A., Scolari V., Rizzo A., Beltrami M., Caimi C., et al. Prevalence of SARS-CoV-2 in an area of unrestricted viral circulation: Mass seroepidemiological screening in Castiglione d’Adda, Italy. PLoS ONE. 2021;16:e0246513. doi: 10.1371/journal.pone.0246513. - DOI - PMC - PubMed
-
- Percivalle E., Cambiè G., Cassaniti I., Nepita E.V., Maserati R., Ferrari A., Di Martino R., Isernia P., Mojoli F., Bruno R., et al. Prevalence of SARS-CoV-2 specific neutralising antibodies in blood donors from the Lodi Red Zone in Lombardy, Italy, as at 06 April 2020. Eurosurveillance. 2020;25:2001031. doi: 10.2807/1560-7917.ES.2020.25.24.2001031. - DOI - PMC - PubMed
-
- Valenti L., Bergna A., Pelusi S., Facciotti F., Lai A., Tarkowski M., Lombardi A., Berzuini A., Caprioli F., Santoro L., et al. SARS-CoV-2 seroprevalence trends in healthy blood donors during the COVID-19 outbreak in Milan. Blood Transfus. 2021;19:181–189. doi: 10.2450/2021.0324-20. - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous